retatrutide ly3437943 clinical trials in healthy participants in a phase 1 single ascending dose Incretin triple agonist retatrutide (LY3437943)
Pay in 4 interest-free payments of $7.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11























